scispace - formally typeset
J

Jelena Dinić

Researcher at University of Belgrade

Publications -  61
Citations -  2041

Jelena Dinić is an academic researcher from University of Belgrade. The author has contributed to research in topics: Cancer cell & Cancer. The author has an hindex of 15, co-authored 53 publications receiving 949 citations. Previous affiliations of Jelena Dinić include Stockholm University & Science for Life Laboratory.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky, +2983 more
- 08 Feb 2021 - 
TL;DR: In this article, the authors present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes.
Journal ArticleDOI

Actin filaments attachment at the plasma membrane in live cells cause the formation of ordered lipid domains.

TL;DR: It is concluded that ordered domains form when actin filaments attach to the plasma membrane, downplays lipid-lipid interactions as the main driving force behind the formation of ordered membrane domains in vivo, giving greater prominence to membrane-intracellular filament interactions.
Journal ArticleDOI

Laurdan and di-4-ANEPPDHQ do not respond to membrane-inserted peptides and are good probes for lipid packing.

TL;DR: The results suggest that the presence of proteins in biological membranes does not influence the spectra of laurdan and di-4-ANEPPDHQ, supporting that the dyes are appropriate probes for assessing lipid order in cells.
Journal ArticleDOI

Limited cholesterol depletion causes aggregation of plasma membrane lipid rafts inducing T cell activation.

TL;DR: It is concluded that non-lethal cholesterol depletion causes the aggregation of lipid rafts which then induces T cell signalling.
Journal ArticleDOI

Repurposing old drugs to fight multidrug resistant cancers

TL;DR: A timely and comprehensive overview of compounds with considerable potential to be repositioned for cancer therapeutics, including drugs from diverse chemotherapeutic classes that have shown extensive immunomodulatory, antiproliferative, pro-apoptotic, and antimetastatic potential.